Figure 1.

Graphical representation of the complexity of possible situations of misuse and individuals involved. On the left “appropriate” use is simplified based on health authority standards (HAS, ANSM) or professional societies, and consistent with the summary of product characteristics. On the right, the various situations of misuse are identified with the identification of individuals. Adapted according to [1], [2], [24]. MA: marketing authorisation; FR: risk factor; RCP: summary of product characteristics